GGG

GENTIAN DIAGNOSTICS ASA

No trades
See on Supercharts
Market capitalization
‪555.20 M‬NOK
‪−10.65 M‬NOK
‪135.15 M‬NOK
‪9.33 M‬
Beta (1Y)
−0.01

About GENTIAN DIAGNOSTICS ASA

CEO
Hilja Ibert
Website
Headquarters
Moss
Employees (FY)
58
Founded
2001
ISIN
NO0010748866
FIGI
BBG00FJC6841
Gentian Diagnostics ASA engages in the research, development, production, marketing, and distribution of immunoassays. Its products include GCAL Calprotrectin, Crystatin C, Retinol-Binding Protein, Canine CRP, SARS-CoV-2 Total Ab, NT-proBNP Pre-Launch, BÜHLMANN products, IFU documents, and safety data sheets. The company was founded by Erling M. H. Sundrehagen and Bård Sundrehagen in 2001 and is headquartered in Moss, Norway.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of GENT is 36.6 NOK — it has increased by 1.67% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OSL exchange GENTIAN DIAGNOSTICS ASA stocks are traded under the ticker GENT.
GENTIAN DIAGNOSTICS ASA is going to release the next earnings report on Apr 30, 2024. Keep track of upcoming events with our Earnings Calendar.
GENT stock is 2.73% volatile and has beta coefficient of −0.01. Check out the list of the most volatile stocks — is GENTIAN DIAGNOSTICS ASA there?
One year price forecast for GENTIAN DIAGNOSTICS ASA has a max estimate of 54.0 NOK and a min estimate of 54.0 NOK.
GENT earnings for the last quarter are −0.37 NOK per share, whereas the estimation was −0.37 NOK resulting in a −1.78% surprise. The estimated earnings for the next quarter are −0.13 NOK per share. See more details about GENTIAN DIAGNOSTICS ASA earnings.
GENTIAN DIAGNOSTICS ASA revenue for the last quarter amounts to ‪25.12 M‬ NOK despite the estimated figure of ‪24.42 M‬ NOK. In the next quarter revenue is expected to reach ‪30.51 M‬ NOK.
Yes, you can track GENTIAN DIAGNOSTICS ASA financials in yearly and quarterly reports right on TradingView.
GENT stock has fallen by 1.08% compared to the previous week, the month change is a 4.19% fall, over the last year GENTIAN DIAGNOSTICS ASA has showed a 11.81% decrease.
GENT net income for the last quarter is ‪−9.79 M‬ NOK, while the quarter before that showed ‪−816.00 K‬ NOK of net income which accounts for ‪−1.10 K‬% change. Track more GENTIAN DIAGNOSTICS ASA financial stats to get the full picture.
Today GENTIAN DIAGNOSTICS ASA has the market capitalization of ‪555.21 M‬, it has decreased by 1.04% over the last week.
No, GENT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, GENT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GENTIAN DIAGNOSTICS ASA stock right from TradingView charts — choose your broker and connect to your account.
GENT reached its all-time high on Aug 27, 2020 with the price of 89.0 NOK, and its all-time low was 22.0 NOK and was reached on Dec 14, 2016.
See other stocks reaching their highest and lowest prices.
As of Apr 20, 2024, the company has 58.00 employees. See our rating of the largest employees — is GENTIAN DIAGNOSTICS ASA on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GENTIAN DIAGNOSTICS ASA technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GENTIAN DIAGNOSTICS ASA stock shows the strong sell signal. See more of GENTIAN DIAGNOSTICS ASA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on GENTIAN DIAGNOSTICS ASA future price: according to them, GENT price has a max estimate of 54.00 NOK and a min estimate of 54.00 NOK. Read a more detailed GENTIAN DIAGNOSTICS ASA forecast: see what analysts think of GENTIAN DIAGNOSTICS ASA and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GENTIAN DIAGNOSTICS ASA EBITDA is ‪−3.92 M‬ NOK, and current EBITDA margin is −5.18%. See more stats in GENTIAN DIAGNOSTICS ASA financial statements.